SG Americas Securities
UTHR icon

SG Americas Securities’s United Therapeutics UTHR Stock Holding History

SG Americas Securities’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,000
Closed -$40K – 3826
2021
Q3 		$40K Buy
+10,000
New +$1.97M ﹤0.01% 3753

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

SG Americas Securities's UTHR Position: Q1 2026 in Review

SG Americas Securities reduced its United Therapeutics (UTHR) stake by 14% in Q1 2026, selling an estimated $1.92M and leaving 23,113 shares worth $13.7M. The position accounts for 0.01% of the portfolio, ranked #682.

SG Americas Securities first reported a position in UTHR in Q2 2013 and has held it in 50 quarters since. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • SG Americas Securities held 23,113 shares of United Therapeutics worth $13.7M as of Q1 2026.
  • SG Americas Securities sold 3,847 United Therapeutics shares in Q1 2026, an estimated $1.92M.
  • United Therapeutics made up 0.01% of SG Americas Securities's portfolio in Q1 2026, its #682 holding.
  • SG Americas Securities first reported a position in United Therapeutics in Q2 2013 and has held it in 50 quarters since.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.